1] Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo 113-0033, Japan [2] Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Cell Res. 2014 Jan;24(1):69-79. doi: 10.1038/cr.2013.161. Epub 2013 Dec 10.
Autophagy is a major intracellular degradative process that delivers cytoplasmic materials to the lysosome for degradation. Since the discovery of autophagy-related (Atg) genes in the 1990s, there has been a proliferation of studies on the physiological and pathological roles of autophagy in a variety of autophagy knockout models. However, direct evidence of the connections between ATG gene dysfunction and human diseases has emerged only recently. There are an increasing number of reports showing that mutations in the ATG genes were identified in various human diseases such as neurodegenerative diseases, infectious diseases, and cancers. Here, we review the major advances in identification of mutations or polymorphisms of the ATG genes in human diseases. Current autophagy-modulating compounds in clinical trials are also summarized.
自噬是一种重要的细胞内降解过程,它将细胞质物质输送到溶酶体进行降解。自 20 世纪 90 年代发现自噬相关(Atg)基因以来,已有大量研究探讨自噬在各种自噬基因敲除模型中的生理和病理作用。然而,最近才出现了自噬基因功能障碍与人类疾病之间关联的直接证据。越来越多的报道表明,在各种人类疾病中,如神经退行性疾病、传染病和癌症中,都发现了 ATG 基因的突变。在这里,我们综述了在人类疾病中鉴定 ATG 基因突变或多态性的主要进展。还总结了目前临床试验中正在使用的自噬调节化合物。